Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.78 |
| ▸ | SLC1A3 | P43003 | 6/20 | 0.61 |
| ▸ | SLC1A2 | P43004 | 6/20 | 0.61 |
| ▸ | SLC1A1 | P43005 | 6/20 | 0.57 |
| ▸ | GRIK1 | P39086 | 8/20 | 0.44 |
| ▸ | GRIK2 | Q13002 | 5/20 | 0.44 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.43 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.43 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.41 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.41 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.41 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.41 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Leucine SCHEMBL17184327 | 1.00 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL4394463 | 1.00 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL4401591 | 1.00 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL375261 | 1.00 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL466382 | 1.00 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL28161805 | 1.00 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL17184328 | 1.00 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| D-Leucine SCHEMBL11768667 | 1.00 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL11305893 | 1.00 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL2553000 | 0.96 | SLC7A5 (0.72) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3716762-A1 | METHOD FOR THE CRYOPRESERVATION OF CELLS FOR THERAPEUTIC PURPOSES | Laboratoire Français du Fractionnement et des Biotechnologies (FR) | 2020-10-07 | — | — | EP | claimed |
| US-10381112-B2 | Method and system for characterizing allergy-related conditions associated with microorganisms | uBiome, Inc. (US) | 2019-08-13 | — | — | US | claimed |
| EP-3474849-A1 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DIABETES | The Broad Institute, Inc. (US) | 2019-05-01 | — | — | EP | claimed |
| WO-2018005445-A1 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DIABETES | THE BROAD INSTITUTE, INC. (US) | 2018-01-04 | — | — | WO | claimed |
| US-RE41287-E1 | modulate the activity of G protein-coupled receptors and are useful in the treatment of conditions mediated by G protein-coupled receptors, for example, inflammatory conditions; rheumatoid arthritis | PROMICS PTY LIMITED (AU) | 2010-04-27 | — | — | US | claimed |
| US-20050197398-A1 | Therapeutic agent for hepatic disease | AJINOMOTO CO., INC (JP) | 2005-09-08 | — | — | US | claimed |
| EP-1084137-A1 | PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2001-03-21 | — | — | EP | claimed |
| WO-1999064442-A1 | PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI S.P.A. (IT) | 1999-12-16 | — | — | WO | claimed |
| US-5955340-A | DNA CODING POLYPEPTIDE WITH ALTERED HEAT OXIDATION AND ALKALI RESISTANCE, SUBSTRATE SPECIFICITY AND ENZYME KINETICS | GENENCOR INTERNATIONAL, INC. (US) | 1999-09-21 | — | — | US | claimed |
| EP-0413528-B1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | YU RUEY J (US) | 1995-11-15 | — | — | EP | claimed |
| WO-1992011286-A1 | OXIDATION RESISTANT VARIANTS OF PARATHYROID HORMONE | ALLELIX BIOPHARMACEUTICALS INC. (CA) | 1992-07-09 | — | — | WO | claimed |
| EP-0115713-A1 | 2-(1-Piperazinyl)-pyrimidines, their salts, process for their preparation and pharmaceutical compositions containing them | SANOFI S.A. (FR) | 1984-08-15 | — | — | EP | claimed |
| CN-120129690-A | Dual receptor targeted radioligands and uses thereof | 辐联科技香港有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-118326031-A | System for identifying traditional Chinese medicine symptoms of rheumatoid arthritis through molecular markers | 中国中医科学院中药研究所 | 2024-07-12 | — | — | CN | disclosed |
| WO-2024143514-A1 | PURIFICATION METHOD AND PRODUCTION METHOD OF CYCLIC PEPTIDE | 中外製薬株式会社 | 2024-07-04 | — | — | WO | disclosed |
| US-20240158865-A1 | Markers of Triple-Negative Breast Cancer and Uses Thereof | VANDERBILT UNIVERSITY | 2024-05-16 | — | — | US | disclosed |
| WO-1991005564-A1 | SYNTHESIS AND USE OF AMINO ACID FLUORIDES AS PEPTIDE COUPLING REAGENTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-05-02 | — | — | WO | disclosed |
| EP-0400010-A1 | SOLUBLE HUMAN CD4 FRAGMENTS AND USES THEREFOR | DANA-FARBER CANCER INSTITUTE (US) | 1990-12-05 | — | — | EP | disclosed |
| WO-1989003222-A1 | SOLUBLE HUMAN CD4 FRAGMENTS AND USES THEREFOR | DANA-FABER CANCER INSTITUTE (US) | 1989-04-20 | — | — | WO | disclosed |
| EP-0280673-A2 | Method for production of inorganic minute globular particles | Nippon Shokubai Kagaku Kogyo Co., Ltd (JP) | 1988-08-31 | — | — | EP | disclosed |